REXR(REXR)
REXR
Q4 2026 EPS Estimate
$0.33
Oct 21, 2026 · Reports after close
Revenue Estimate
$238M
FY2026E EPS$0.75
FY2027E EPS$1.21
Analyst Sentiment
Wall St. Consensus
Hold20 analysts·High coverage
61
Score
11 Buy (55%)7 Hold (35%)2 Sell (10%)
Rating Breakdown
Strong Buy
00%
Buy
1155%
Hold
735%
Sell
210%
Strong Sell
00%
Analyst ratings reflect Wall Street opinion, not guarantees. Historical accuracy varies by firm and sector.
Price Target Expectations
Bear
$35.00
-3.9%
Consensus
$37.00
+1.6%
Bull
$40.00
+9.8%
12-Month Target Range20 analysts
$35.00$37.00$40.00
Current $36.42Consensus
Current Price
$36.42
Upside to Consensus
$0.58
Price targets are 12-month analyst forecasts. Actual results depend on earnings, market conditions, and sector trends.
Earnings & Revenue Estimates
Forward Growth Estimates (YoY)
FY2027
Rev-1.74%
EPS+60.40%
FY2028
Rev+2.48%
EPS-11.93%
FY2029
Rev+4.98%
EPS+0.00%
Raw consensus estimates (low / average / high) from covering analysts.
Annual
| Metric | FY2026E | FY2027E | FY2028E | FY2029E | FY2030E |
|---|---|---|---|---|---|
| Revenue Avg | $957M | $941M | $964M | $1.01B | $1.09B |
| Low | $954M | $918M | $846M | $958M | $1.03B |
| High | $961M | $959M | $1.05B | $1.06B | $1.14B |
| EBITDA Avg | $650M | $639M | $655M | $687M | $740M |
| Low | $648M | $624M | $574M | $650M | $700M |
| High | $653M | $651M | $713M | $718M | $774M |
| EBIT Avg | $338M | $332M | $340M | $357M | $384M |
| Low | $337M | $324M | $298M | $338M | $364M |
| High | $339M | $338M | $371M | $373M | $402M |
| Net Income Avg | $175M | $292M | $246M | $248M | $295M |
| Low | $175M | $269M | $230M | $230M | $275M |
| High | $176M | $294M | $262M | $262M | $313M |
| EPS Avg | $0.75 | $1.21 | $1.06 | $1.06 | $1.27 |
| Low | $0.75 | $1.16 | $0.99 | $0.99 | $1.18 |
| High | $0.76 | $1.27 | $1.13 | $1.13 | $1.35 |
| Analysts (Rev / EPS) | 5 / 2 | 6 / 3 | 4 / 1 | 2 / 1 | 2 / 1 |
Quarterly
| Metric | Q3 2026 | Q4 2026 | Q1 2027 | Q2 2027 | Q3 2027 | Q4 2027 | Q1 2028 | Q2 2028 |
|---|---|---|---|---|---|---|---|---|
| Revenue Avg | $238M | $237M | $232M | $234M | $235M | $237M | $253M | $259M |
| Low | $237M | $237M | $230M | $231M | $233M | $234M | $250M | $256M |
| High | $239M | $237M | $235M | $236M | $238M | $240M | $256M | $262M |
| EBITDA Avg | $162M | $161M | $158M | $159M | $160M | $161M | $172M | $176M |
| Low | $161M | $161M | $156M | $157M | $158M | $159M | $170M | $174M |
| High | $162M | $161M | $159M | $160M | $162M | $163M | $174M | $178M |
| EBIT Avg | $84M | $84M | $82M | $83M | $83M | $84M | $89M | $91M |
| Low | $84M | $83M | $81M | $82M | $82M | $83M | $88M | $90M |
| High | $84M | $84M | $83M | $83M | $84M | $85M | $90M | $92M |
| Net Income Avg | $71M | $64M | $56M | $52M | $51M | $52M | — | — |
| Low | $70M | $62M | $55M | $51M | $50M | $52M | — | — |
| High | $72M | $65M | $57M | $53M | $52M | $53M | — | — |
| EPS Avg | $0.32 | $0.28 | $0.25 | $0.23 | $0.23 | $0.23 | — | — |
| Low | $0.31 | $0.28 | $0.25 | $0.23 | $0.22 | $0.23 | — | — |
| High | $0.32 | $0.29 | $0.25 | $0.24 | $0.23 | $0.24 | — | — |
| Analysts (Rev / EPS) | 4 / 2 | 4 / 2 | 2 / 1 | 2 / 1 | 2 / 1 | 2 / 1 | 1 / 1 | 1 / 1 |